image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Judges Scientific

November 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • JDG
  • Price:
  • 6900p
Judges delighted investors with the news that it now expects to significantly beat market expectations for the full year. Organic orders remain positive and to the end of August are 3% up versus 2021 with  the organic order book at the end of August at 21 weeks. Even better, a strong second half is anticipated from Geotek, the largest acquisition in its history, which is now expected to trigger the full earn-out payable. While inflation remains a concern, Sterling weakness offsets it, given its strong overseas earnings.Liberum has upgraded eps forecasts 15% and 5% for this year and next, respectively, to 335p and 365p, dropping next year’s prospective PE to 18.9 and has increased its price target by £5 to £100. Solid hold ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Judges Scientific (June 2024)
Judges Scientific - Shares soar to remarkable £112 (April 2024)
Judges Scientific (March 2024)
Judges Scientific (September 2023)
Judges Scientific (May 2023)
Judges Scientific (July 2022)
Judges Scientific (May 2022)
Judges Scientific - Eps to be ahead of expectations (February 2022)
Judges Scientific - Extraordinary total shareholder returns for scientific instruments group (December 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X